28.09.2015
- US pharmaceutical giant Pfizer has exercised its option under the companies’ global collaboration agreement to take an exclusive license from Bind Therapeutics for the purpose of...
31.08.2015
- Amgen has won US Food and Drug Administration (FDA) approval for Repatha, the second medicine in a new class of biologics recently greenlighted by the agency and claimed to reduce...
28.08.2015
- US pharma company Alvogen has agreed to buy four of Pfizer’s products in the USA. The sale is part of Pfizer’s condition in closing its $17 billion acquisition of Hospira. The...
26.08.2015
- Pfizer can now progress its $17 billion purchase of Hospira after receiving final regulatory approvals from the USA and Brazil. The clearance from the US Federal Trade Commission...
06.08.2015
- European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...
22.07.2015
- US drugmaker Pfizer has more collaborations with British universities than any other foreign company, according to the newly published Dowling Review conducted by Ann Dowling...
06.07.2015
- ViiV Healthcare, the HIV unit of GlaxoSmithKline, has signed an agreement with Shanghai-based Desano Pharmaceuticals under which the Chinese group will produce the active...
24.06.2015
- Pfizer has agreed to acquire the quadrivalent meningitis ACWY vaccines Nimenrix and Mencevax from GlaxoSmithKline (GSK) for €115 million. The deal, expected to close in the second...
